ALNYLAM PHARMACEUTICALS, INC. - COM (ALNY)

Q3 2016 13F Portfolio Holders as of 9/30/2016

Type / Class
Equity / COM
Number of holders
253
Total Shares
77.5M
Shares change
+3.28M
Total reported value, excl. options
$5.25B
Value change
+$229M
Put/Call ratio
0.56
Number of buys
107
Number of sells
-100
Price
$67.78
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.